Feedback / Questions
tuspetinib (HM43239) - Aptose Biosci
https://www.globenewswire.com/news-release/2025/12/06/3201046/35575/en/Aptose-s-Tuspetinib-Triple-Drug-Therapy-Featured-at-the-2025-ASH-Annual-Meeting-High-Rate-of-Frontline-Clinical-Responses-Continues-Across-AML-Populations.html
Dec 6, 2025
SHARE THIS
Print
Email
More sharing
Reddit
StumbleUpon
Delicious
Next